Dyne Therapeutics, Inc. Profile Avatar - Palmy Investing

Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenn…

Biotechnology
US, Waltham [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Dyne Therapeutics, Inc. can't present it's latest revenue by geo. area

Historical Revenue By Segment

Last 3Y, in mil. USD

Dyne Therapeutics, Inc. can't present revenue by segment

End of DYN's Analysis
CIK: 1818794 CUSIP: 26818M108 ISIN: US26818M1080 LEI: - UEI: -
Secondary Listings
DYN has no secondary listings inside our databases.